Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMA8Z4N)

Drug Name

SB-318 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Mucopolysaccharidosis	5C56.3	Phase 1/2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Alpha-L-iduronidase (IDUA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RGX-111	DMU87HW	Mucopolysaccharidosis	5C56.3	Phase 1	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT02702115) Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of REGENXBIO.